NILCO could represent the integration of developmental, pro-inflammatory and pro-angiogenic signals critical for leptin-induced breast cancer cell proliferation/migration, tumor angiogenesis and breast cancer stem cells. This evidence concerns the gene LEP and breast carcinoma.